ProCE Banner Activity

Diapositivas: estudios clave sobre el VIH que influirán en mi práctica tras la IDWeek y el HIV Glasgow de 2022

Slideset Download
Conference Coverage

Consulte los resúmenes de estudios clave sobre el VIH presentados en la Semana de las Enfermedades Infecciosas (IDWeek 2022) y el Congreso Internacional sobre Terapia Farmacológica del VIH (HIV Glasgow 2022) que ha redactado un panel de expertos y que incluyen los resultados de estudios relativos a las estrategias de prevención, los tratamientos de acción prolongada, los tratamientos diarios de administración oral, los fármacos en fase de investigación, el VIH y la COVID-19.

Released: December 16, 2022

Share

Faculty

Karine Lacombe

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities 
Dean for Healthcare Transformation
Queen Mary University of London
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Karine Lacombe, MD, PhD: consultant/advisor/speaker: Gilead, Merck Sharp & Dohme, Viiv Healthcare.

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities 
Dean for Healthcare Transformation
Queen Mary University of London
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GlaxoSmithKline, Merck Sharp & Dohme, ViiV.